DrugPatentWatch Database Preview
Abbvie Company Profile
» See Plans and Pricing
US Patents for Abbvie
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 9,976,171 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) | 2040-03-30 | search | ||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 9,867,806 | Galapagos NV (Mechelen, BE) | 2033-05-07 | search | ||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 9,700,564 | Horizon Orphan LLC (Lake Forest, IL) | 2029-09-04 | search | ||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 9,592,211 | 2032-09-19 | search | |||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 9,056,126 | ASCENDIS PHARMA A/S (Hellerup, DK) | 2024-07-05 | search | ||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 8,980,242 | Ascendis Pharma GmbH (Hellerup, DK) | 2025-06-22 | search | ||
| Abbvie Inc. | CREON | pancrelipase | CAPSULE, DELAYED RELEASE PELLETS | 020725 | 1 | 2013-03-14 | 8,906,847 | Ascendis Pharma A/S (Hellerup, DK) | 2028-02-01 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
